Home › Compare › PZRXQ vs SCHD

PZRXQ vs SCHD: Dividend Comparison 2026

PZRXQ yields 2000000.00% · SCHD yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PZRXQ wins by $4.879226400974806e+39M in total portfolio value
10 years
PZRXQ
PZRXQ
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full PZRXQ calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.44%
Share price
$30.68
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$422.61
Full SCHD calculator →

Portfolio growth — PZRXQ vs SCHD

📍 PZRXQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPZRXQSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PZRXQ + SCHD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PZRXQ pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PZRXQ
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$292.49/yr
After 10yr DRIP, annual income (after tax)
$359.22/yr
At 15% tax rate, PZRXQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PZRXQ + SCHD for your $10,000?

PZRXQ: 50%SCHD: 50%
100% SCHD50/50100% PZRXQ
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PZRXQ buys
0
SCHD buys
0
No recent congressional trades found for PZRXQ or SCHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPZRXQSCHD
Forward yield2000000.00% ✓3.44%
Annual dividend / share$2.00 ✓$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$29.0K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$422.61
Total dividends collected$4.879195005460081e+39M ✓$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PZRXQ vs SCHD ($10,000, DRIP)

YearPZRXQ PortfolioPZRXQ Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,224$344.10+$200.00M → PZRXQ
2$3,738,731,768,458$3,738,517,757,009.35$12,567$354.98+$3738731.76M → PZRXQ
3$65,315,062,866,930,490$65,311,062,423,938,240.00$14,038$365.30+$65315062866.92M → PZRXQ
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$15,648$375.06+$1066400830062625.00M → PZRXQ
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$17,410$384.27+$16272182796453826560.00M → PZRXQ
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$19,335$392.95+$2.3205424011366188e+23M → PZRXQ
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$21,437$401.10+$3.0927990661046884e+27M → PZRXQ
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$23,733$408.75+$3.8524105697352695e+31M → PZRXQ
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$26,237$415.91+$4.484688260147987e+35M → PZRXQ
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$28,968$422.61+$4.879226400974806e+39M → PZRXQ

PZRXQ vs SCHD: Complete Analysis 2026

PZRXQ — Stock

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

Full PZRXQ Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this PZRXQ vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PZRXQ vs JEPIPZRXQ vs OPZRXQ vs KOPZRXQ vs MAINPZRXQ vs VYMPZRXQ vs DGROPZRXQ vs VIGPZRXQ vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.